-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Quince Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2024.
- Quince Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $7K, a 86.3% decline year-over-year.
- Quince Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $87K.
- Quince Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $87K.
- Quince Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$197K, a 30.6% increase from 2022.
- Quince Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$284K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)